Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome

Simon, 1993, The cytokeratin filament-aggregating protein filaggrin is the target of the so-called “antikeratin antibodies” autoantibodies specific for rheumatoid arthritis, J. Clin. Invest., 92, 1387, 10.1172/JCI116713 Lundberg, 2013, Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile, Ann. Rheum. Dis., 72, 652, 10.1136/annrheumdis-2012-201484 de Pablo, 2014, The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis?, Ann. Rheum. Dis., 73, 580, 10.1136/annrheumdis-2012-202701 Goules, 2013, Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis, Clin. Exp. Immunol., 174, 10, 10.1111/cei.12145 Mahdi, 2009, Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis, Nat. Genet., 41, 1319, 10.1038/ng.480 Fisher, 2011, Antibodies to citrullinated alpha-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis, Ann. Rheum. Dis., 70, 1095, 10.1136/ard.2010.138909 Bournia, 2012, Subgroups of Sjogren syndrome patients according to serological profiles, J. Autoimmun., 39, 15, 10.1016/j.jaut.2012.03.001 Kim, 2012, The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjogren syndrome, Rheumatol. Int., 32, 3963, 10.1007/s00296-011-2274-3 ter Borg, 2016, Polyarthritis in primary Sjogren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up, Clin. Rheumatol., 35, 649, 10.1007/s10067-016-3175-3 Atzeni, 2008, Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis, Arthritis Res. Ther., 10, R51, 10.1186/ar2420 Iwamoto, 2009, Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies, J. Rheumatol., 36, 113, 10.3899/jrheum.080193 Gottenberg, 2005, Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome, Ann. Rheum. Dis., 64, 114, 10.1136/ard.2003.019794 Vitali, 2002, Group on classification criteria for Sjogren's, classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group, Ann. Rheum. Dis., 61, 554, 10.1136/ard.61.6.554 Aletaha, 2010, Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum., 62, 2569, 10.1002/art.27584 Gravani, 2015, Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations, Arthritis Res. & Ther., 17, 99, 10.1186/s13075-015-0613-6 Bae, 2012, Alpha-enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis, J. Immunol., 189, 365, 10.4049/jimmunol.1102073 Moutsopoulos, 1991, Nephrocalcinosis in Sjogren's syndrome: a late sequela of renal tubular acidosis, J. Intern. Med., 230, 187, 10.1111/j.1365-2796.1991.tb00429.x Goules, 2000, Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome, Medicine, 79, 241, 10.1097/00005792-200007000-00005 Takemoto, 2005, Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome, Am. J. Med., 118, 181, 10.1016/j.amjmed.2004.07.049 Kanlaya, 2013, Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion, J. Proteome, 80, 55, 10.1016/j.jprot.2013.01.001